iifl-logo

Quant Healthcare Fund Direct G

Quant Healthcare Fund Direct G

Fund Name

Quant Mutual Fund

Scheme Name

Quant Healthcare Fund Direct G

AMC

Quant Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

27-Jun-2023

Fund Manager

Sandeep Tandon

Net Assets (Rs. cr)

384.01

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Quant Healthcare Fund Direct G - Nav Details

Nav Date

:  08-Oct-2025

NAV [Rs.]

:  15.9038

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Quant Healthcare Fund Direct G- NAV Chart

Quant Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.29
0.41
-3.57
15.41
-7.06
-
-
22.95
Category Avg
2.03
-0.7
-1.32
12.29
0.93
22.73
17.51
15.7
Category Best
2.87
0.77
1.42
17.08
10.68
27.93
20.75
32.07
Category Worst
1.54
-1.46
-4.31
8.02
-8.58
19.31
13.48
-3.84

Quant Healthcare Fund Direct G- Latest Dividends

No Records Found

Quant Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Max Healthcare1,41,381
Laxmi Dental2,87,210

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityAster DM Health.Healthcare Services10.3762676539.29
EquityRPG LifeScience.Pharmaceuticals & Biotechnology8.8715052933.63
EquityZydus WellnessFood Products7.7464173029.33
EquitySequent Scien.Pharmaceuticals & Biotechnology7.26147712627.51
EquityAnthem BiosciencPharmaceuticals & Biotechnology6.7033355425.39
EquityPfizerPharmaceuticals & Biotechnology6.374795424.14
EquityAurobindo PharmaPharmaceuticals & Biotechnology6.2121730023.55
EquityAlivus LifePharmaceuticals & Biotechnology6.0424629822.88
EquityHDFC Life Insur.Insurance5.9329740622.49
EquitySMS Pharma.Pharmaceuticals & Biotechnology5.4083321320.46
EquityConcord BiotechPharmaceuticals & Biotechnology3.638347213.75
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology3.257724912.31
EquityLupinPharmaceuticals & Biotechnology2.875697610.88
EquityGland PharmaPharmaceuticals & Biotechnology1.47280765.59

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Quant Mutual Fund
Incorporation Date:
01-Dec-1995
Total Assets Managed (Cr.):
96,240.54
Trustee/s:
Quant Capital Trustee Lim, Mr. Deba Prasad Roy
Chairman:
NA
CEO / MD:
Mr. Sandeep Tandon
CIO:
NA
President:
NA
Director/s:
Mr. Deep Shukla, Mr.Vasav Sahgal, Sandeep Tandon, Mr. Laxmikant Gupta, Mr. Sandeep Tandon, Mr. Deep Shukla, Mr. Bhaskar Sharma
Compliance Officer/s:
Ms. Usha Lakshmi Raman
Investor Service Officer/s:
Mr. Shardul Gusain
Fund Manager/s:
Sandeep Tandon
Auditors:
M M Nissim & Co LLP

OTHER INFORMATION

Registered Office:
6th Floor, Sea Breeze Building, Appasaheb Marathe Marg, Prabhadevi Mumbai - 400025
Contact Nos:
022-62955000
Fax:
NA
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.